Biol Reprod Keystone Symposia Conference on Frontiers in Reproductive Biology & Regulation of Fertility.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

BOR - Papers in Press, published online ahead of print June 7, 2006.
Biol Reprod 2006, 10.1095/biolreprod.106.050831
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
75/3/342    most recent
biolreprod.106.050831v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tosca, L.
Right arrow Articles by Dupont, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tosca, L.
Right arrow Articles by Dupont, J.
Agricola
Right arrow Articles by Tosca, L.
Right arrow Articles by Dupont, J.
BIOLOGY OF REPRODUCTION 75, 342–351 (2006)
DOI: 10.1095/biolreprod.106.050831
© 2006 by the Society for the Study of Reproduction, Inc.

Research Article

Metformin-Induced Stimulation of Adenosine 5' Monophosphate-Activated Protein Kinase (PRKA) Impairs Progesterone Secretion in Rat Granulosa Cells1

Lucie Tosca 3, Patricia Solnais 3, Pascal Ferré 4, Fabienne Foufelle 4, and Joëlle Dupont 2 3

Unité de Physiologie de la Reproduction et des Comportements,3 Institut National de la Recherche Agronomique, 37380 Nouzilly, France U671 INSERM,4 Centre Biomédical des Cordeliers, 75270 Paris, France

ABSTRACT

Metformin is an anti-diabetic drug commonly used to treat cycle disorders and anovulation in women with polycystic ovary syndrome. However, the effects and molecular mechanism of metformin in the ovary are not entirely understood. We investigated the effects of this drug on steroidogenesis and proliferation in rat granulosa cells. Metformin (10 mM) treatment for 48 h reduced progesterone and estradiol (E2) production in both basal conditions and under FSH stimulation. It also decreased the levels of the HSD3B, CYP11A1, STAR, and CYP19A1 proteins in response to FSH (10–8 M) and of HSD3B in the basal state only. Metformin treatment (10 mM, 24 h) also reduced cell proliferation and the levels of CCND2 and CCNE proteins without affecting cell viability, both in the basal state and in response to FSH. Furthermore, metformin treatment for 1 h simultaneously increased the Thr172 phosphorylation of PRKAA (adenosine 5' monophosphate-activated protein kinase alpha) and the Ser79 phosphorylation of ACACA (acetyl-Coenzyme A carboxylase alpha). The adenovirus-mediated production of dominant-negative PRKAA totally abolished the effects of metformin on progesterone secretion, HSD3B and STAR protein production, and MAPK3/1 phosphorylation. Conversely, total inhibition of PRKAA Thr172 phosphorylation with the dominant-negative PRKAA adenovirus did not restore the decrease in E2 production and cell proliferation induced by metformin. Our results therefore strongly suggest that metformin reduces progesterone production via a PRKAA-dependent mechanism, whereas PRKAA activation is not essential for the decrease in E2 production and cell growth induced by metformin in rat granulosa cells.

adenosine 5', monophosphate-activated protein kinase, follicle-stimulating hormone, granulosa cells, kinases, mechanisms of hormone action, ovary, progesterone, steroid hormones

FOOTNOTES

1 Supported by the Région Centre to L.T.

2 Correspondence. FAX: 33 2 47 42 77 43; jdupont{at}tours.inra.fr






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Society for the Study of Reproduction.